24782908|t|GBE50 Attenuates Inflammatory Response by Inhibiting the p38 MAPK and NF- kappa B Pathways in LPS-Stimulated Microglial Cells.
24782908|a|Overactivated microglia contribute to a variety of pathological conditions in the central nervous system. The major goal of the present study is to evaluate the potential suppressing effects of a new type of Ginko biloba extract, GBE50, on activated microglia which causes proinflammatory responses and to explore the underlying molecular mechanisms. Murine BV2 microglia cells, with or without pretreatmentof GBE50 at various concentrations, were activated by incubation with lipopolysaccharide (LPS). A series of biochemical and microscopic assays were performed to measure cell viability, cell morphology, release of tumor necrosis factor- alpha (TNF- alpha ) and interleukin-1 beta (IL-1 beta ), and signal transduction via the p38 MAPK and nuclear factor-kappa B (NF- kappa B) p65 pathways. We found that GBE50 pretreatment suppressed LPS-induced morphological changes in BV2 cells. Moreover, GBE50 treatment significantly reduced the release of proinflammatory cytokines, TNF- alpha and IL-1 beta , and inhibited the associated signal transduction through the p38 MAPK and NF- kappa B p65 pathways. These results demonstrated the anti-inflammatory effect of GBE50 on LPS-activated BV2 microglia cells, and indicated that GBE50 reduced the LPS-induced proinflammatory TNF- alpha and IL-1 beta release by inhibiting signal transduction through the NF- kappa B p65 and p38 MAPK pathways. Our findings reveal, at least in part, the molecular basis underlying the anti-inflammatory effects of GBE50. 
24782908	0	5	GBE50	Chemical	-
24782908	17	29	Inflammatory	Disease	MESH:D007249
24782908	57	65	p38 MAPK	Gene	26416
24782908	70	81	NF- kappa B	Gene	18033
24782908	94	97	LPS	Chemical	MESH:D008070
24782908	335	355	Ginko biloba extract	Chemical	-
24782908	357	362	GBE50	Chemical	-
24782908	400	415	proinflammatory	Disease	
24782908	478	484	Murine	Species	10090
24782908	485	488	BV2	CellLine	CVCL:0182
24782908	537	542	GBE50	Chemical	-
24782908	604	622	lipopolysaccharide	Chemical	MESH:D008070
24782908	624	627	LPS	Chemical	MESH:D008070
24782908	747	775	tumor necrosis factor- alpha	Gene	21926
24782908	777	787	TNF- alpha	Gene	21926
24782908	794	812	interleukin-1 beta	Gene	16176
24782908	814	823	IL-1 beta	Gene	16176
24782908	859	867	p38 MAPK	Gene	26416
24782908	937	942	GBE50	Chemical	-
24782908	967	970	LPS	Chemical	MESH:D008070
24782908	1004	1007	BV2	CellLine	CVCL:0182
24782908	1025	1030	GBE50	Chemical	-
24782908	1105	1115	TNF- alpha	Gene	21926
24782908	1120	1129	IL-1 beta	Gene	16176
24782908	1193	1201	p38 MAPK	Gene	26416
24782908	1268	1280	inflammatory	Disease	MESH:D007249
24782908	1291	1296	GBE50	Chemical	-
24782908	1300	1303	LPS	Chemical	MESH:D008070
24782908	1314	1317	BV2	CellLine	CVCL:0182
24782908	1354	1359	GBE50	Chemical	-
24782908	1372	1375	LPS	Chemical	MESH:D008070
24782908	1384	1399	proinflammatory	Disease	
24782908	1400	1410	TNF- alpha	Gene	21926
24782908	1415	1424	IL-1 beta	Gene	16176
24782908	1499	1507	p38 MAPK	Gene	26416
24782908	1597	1609	inflammatory	Disease	MESH:D007249
24782908	1621	1626	GBE50	Chemical	-
24782908	Association	MESH:D007249	18033
24782908	Association	MESH:D008070	MESH:D007249
24782908	Positive_Correlation	MESH:D008070	21926
24782908	Association	MESH:D007249	26416
24782908	Positive_Correlation	MESH:D008070	16176
24782908	Association	MESH:D008070	26416

